CJC-1295 (DAC)

CJC-1295 with Drug Affinity Complex (DAC) is a modified GHRH analogue with extended plasma half-life achieved through covalent albumin binding. Research demonstrates sustained GHRH receptor activation and prolonged GH/IGF-1 axis stimulation over several days per administration in animal models. Supplied as lyophilized powder for research use only.

Research Use Only. All products sold on this website are strictly for laboratory research, in-vitro testing, and analytical purposes only. Products are not intended for human consumption, diagnostic, therapeutic, or any medical applications. Not evaluated or approved by the FDA.